Status:

COMPLETED

Prediction Model for PPCs in Patients Undergoing Lung Transplantation Using Machine Learning

Lead Sponsor:

Pusan National University Yangsan Hospital

Conditions:

Lung Transplantation

Eligibility:

All Genders

18+ years

Brief Summary

Since the first human lung transplantation in 1963, significant advancements in immunosuppressive agents from the mid-1990s have greatly improved the quantity and quality of such procedures. In 2004, ...

Detailed Description

After the first report of lung transplantation in humans in 1963, rapid advancements in immunosuppressive agents since the mid-1990s have led to significant progress in both the quantity and quality o...

Eligibility Criteria

Inclusion

  • Adult patients 18 years of age or older who underwent lung transplantation for end-stage lung disease

Exclusion

  • None.

Key Trial Info

Start Date :

January 22 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2025

Estimated Enrollment :

214 Patients enrolled

Trial Details

Trial ID

NCT06218758

Start Date

January 22 2024

End Date

June 30 2025

Last Update

August 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pusan National University Yangsan Hospital

Yangsan, South Korea